EISAI CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,989 JPY | +1.82% |
|
+5.13% | -0.28% |
| 05-15 | BioArctic, Eisai Launch Rolling US FDA Application for Leqembi's Maintenance Dosing | MT |
| 05-15 | Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12.55B | ||||||
| 588B | ||||||
| 364B | ||||||
| 326B | ||||||
| 285B | ||||||
| 239B |
- Stock Market
- Equities
- 4523 Stock
- Charts Eisai Co., Ltd.
- Sector Chart